Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects
Elias Björnson, C.J. Packard, Martin Adiels, et al.
Journal of Internal Medicine (2019) Vol. 288, Iss. 4, pp. 422-438
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg, Chris J. Packard, M. John Chapman, et al.
European Heart Journal (2021) Vol. 42, Iss. 47, pp. 4791-4806
Open Access | Times Cited: 529
Causes and Consequences of Hypertriglyceridemia
Chris J. Packard, Jan Borén, Marja‐Riitta Taskinen
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 186
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Jan Borén, Marja‐Riitta Taskinen, Elias Björnson, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 9, pp. 577-592
Closed Access | Times Cited: 144
Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease
Edward Duran, Aruna D. Pradhan
Clinical Chemistry (2020) Vol. 67, Iss. 1, pp. 183-196
Open Access | Times Cited: 90
Remnant lipoproteins: are they equal to or more atherogenic than LDL?
Carlos A. Aguilar‐Salinas, M. John Chapman
Current Opinion in Lipidology (2020) Vol. 31, Iss. 3, pp. 132-139
Open Access | Times Cited: 70
Triglycerides and cardiovascular disease
Oluwayemisi Esan, Anthony S. Wierzbicki
Current Opinion in Cardiology (2021) Vol. 36, Iss. 4, pp. 469-477
Closed Access | Times Cited: 69
The chylomicron saga: time to focus on postprandial metabolism
Alejandro Gugliucci
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 12
<p>Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy</p>
Oluwayemisi Esan, Anthony S. Wierzbicki
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 2623-2636
Open Access | Times Cited: 67
Biosynthesis and Metabolism of ApoB-Containing Lipoproteins
Jan Borén, Marja‐Riitta Taskinen, Chris J. Packard
Annual Review of Nutrition (2024) Vol. 44, Iss. 1, pp. 179-204
Closed Access | Times Cited: 6
Role of circulating sphingolipids in lipid metabolism: Why dietary lipids matter
Catherine Calzada, Cécile Vors, Armelle Penhoat, et al.
Frontiers in Nutrition (2023) Vol. 9
Open Access | Times Cited: 13
Distinct lipoprotein contributions to valvular heart disease: Insights from genetic analysis
Da Luo, Elias Björnson, Xiaoying Wang, et al.
International Journal of Cardiology (2025), pp. 133218-133218
Closed Access
Changes in remnant cholesterol and the incidence of diabetes: Results from two large prospective cohort studies
Yue Shao, Zhenghao Li, Min Sun, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans
C.J. Packard, Marja‐Riitta Taskinen, Elias Björnson, et al.
Atherosclerosis (2025), pp. 119166-119166
Open Access
Effects of liraglutide on the metabolism of triglyceride‐rich lipoproteins in type 2 diabetes
Marja‐Riitta Taskinen, Elias Björnson, Niina Matikainen, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 5, pp. 1191-1201
Open Access | Times Cited: 31
Hypertriglyceridaemia: an update
Anthony S. Wierzbicki, Eun Ji Kim, Oluwayemisi Esan, et al.
Journal of Clinical Pathology (2022) Vol. 75, Iss. 12, pp. 798-806
Closed Access | Times Cited: 20
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy
Marja‐Riitta Taskinen, Niina Matikainen, Elias Björnson, et al.
Diabetologia (2023) Vol. 66, Iss. 12, pp. 2307-2319
Open Access | Times Cited: 11
Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations
Marja‐Riitta Taskinen, Elias Björnson, Niina Matikainen, et al.
JCI Insight (2022) Vol. 7, Iss. 19
Open Access | Times Cited: 16
Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes
Marja‐Riitta Taskinen, Elias Björnson, Juhani Kahri, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2020) Vol. 41, Iss. 2, pp. 962-975
Open Access | Times Cited: 25
Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies
Alejandro Gugliucci
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5229-5229
Open Access | Times Cited: 2
Effects of Early Life Oral Arsenic Exposure on Intestinal Tract Development and Lipid Homeostasis in Neonatal Mice: Implications for NAFLD Development
Xiaojing Yang, André Alberto Weber, Elvira Mennillo, et al.
Environmental Health Perspectives (2023) Vol. 131, Iss. 9
Open Access | Times Cited: 6
Higher ANGPTL3, apoC-III, and apoB48 dyslipidemia, and lower lipoprotein lipase concentrations are associated with dysfunctional visceral fat in adolescents with obesity
Reyna Rodríguez-Mortera, Russell Caccavello, Ma. Eugenia Garay‐Sevilla, et al.
Clinica Chimica Acta (2020) Vol. 508, pp. 61-68
Closed Access | Times Cited: 17
Metabolism of Triglyceride-Rich Lipoproteins
Jan Borén, Marja‐Riitta Taskinen
Handbook of experimental pharmacology (2021), pp. 133-156
Open Access | Times Cited: 14
Role of apolipoproteins in the pathogenesis of obesity
Mingjing Huang, Jingyi Zheng, Lijun Chen, et al.
Clinica Chimica Acta (2023) Vol. 545, pp. 117359-117359
Closed Access | Times Cited: 5
Effects of PNPLA3 I148M on hepatic lipid and very‐low‐density lipoprotein metabolism in humans
Jan Borén, Martin Adiels, Elias Björnson, et al.
Journal of Internal Medicine (2021) Vol. 291, Iss. 2, pp. 218-223
Open Access | Times Cited: 12
Lean adolescents with insulin resistance display higher angiopoietin like protein 3, ApoC-III and chylomicron remnant dyslipidemia
Karla Paola Gutiérrez-Castro, Alma Patricia González, Russell Caccavello, et al.
Clinica Chimica Acta (2021) Vol. 526, pp. 43-48
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top